Title | Pancreas regeneration. |
Publication Type | Journal Article |
Year of Publication | 2018 |
Authors | Zhou Q, Melton DA |
Journal | Nature |
Volume | 557 |
Issue | 7705 |
Pagination | 351-358 |
Date Published | 2018 May |
ISSN | 1476-4687 |
Keywords | Adult Stem Cells, Animals, Cell Proliferation, Cellular Reprogramming, Humans, Islets of Langerhans, Pancreas, Pluripotent Stem Cells, Regeneration, Regenerative Medicine |
Abstract | <p>The pancreas is made from two distinct components: the exocrine pancreas, a reservoir of digestive enzymes, and the endocrine islets, the source of the vital metabolic hormone insulin. Human islets possess limited regenerative ability; loss of islet β-cells in diseases such as type 1 diabetes requires therapeutic intervention. The leading strategy for restoration of β-cell mass is through the generation and transplantation of new β-cells derived from human pluripotent stem cells. Other approaches include stimulating endogenous β-cell proliferation, reprogramming non-β-cells to β-like cells, and harvesting islets from genetically engineered animals. Together these approaches form a rich pipeline of therapeutic development for pancreatic regeneration.</p> |
DOI | 10.1038/s41586-018-0088-0 |
Alternate Journal | Nature |
PubMed ID | 29769672 |
PubMed Central ID | PMC6168194 |
Grant List | R01 DK106253 / DK / NIDDK NIH HHS / United States UC4 DK116280 / DK / NIDDK NIH HHS / United States / HHMI / Howard Hughes Medical Institute / United States |